Mannkind Corp
NASDAQ:MNKD 4:00:00 PM EDT
| Market Cap (Intraday) | 1.06B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | 26.87 |
| 10-Day MA | $4.14 |
| 50-Day MA | $4.86 |
| 200-Day MA | $4.20 |
Mannkind Corp Stock, NASDAQ:MNKD
1 Casper Street, Suite 300, Danbury, Connecticut 06810
United States of America
Phone: +1.818.661.5000
Number of Employees: 395
Description
MannKind Corp. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic products and devices for those with endocrine and orphan lung diseases. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.